What could you do if your data was working for you and not against you? With Bloomberg delivering

enterprise data directly to your systems, you get easy access to the details you want, optimized for

higher level analysis, and financial data experts committed to helping you maximize your every move.

Our data is made for more, so you can show the world what you're made of. Visit Bloomberg.com slash enterprise data to learn more.

Welcome to Prognosis. I'm Laura Carlson. It's day 352 since coronavirus was declared a global pandemic.

Today's main story, Johnson & Johnson's one-shot vaccine has been approved by regulators.

We asked the CEO, how he plans to increase supply to get 100 million people vaccinated by summer.

But first, here's what happened in virus news today. The Biden administration has already begun shipping almost 4 million doses of Johnson & Johnson's COVID-19 vaccine.

On Sunday, the Centers for Disease Control and Prevention formally recommended the

shot for adults. Now that all regulatory hurdles have been cleared, providers can finally start

administering doses of the first one-shot vaccine. The first deliveries of the vaccine will arrive as early as Tuesday.

That's according to senior administration officials who held a briefing call on condition

of anonymity.

The officials said the shots will be shipped through every distribution channel, including

to states on a per capita basis, as well as directly to pharmacies

and community health centers.

The UK is trying to trace a person infected with the Brazilian variant of the coronavirus.

Six cases of the mutation, which originated in the Amazonian city of Manaus, have been detected

in the UK.

While five have been found, the identity of the final patient is still unknown, because they

failed to complete a test registration card, leaving health officials without the information

needed to find them.

...